-
Five-drug combination for ultra-high-risk bone marrow cancer identified
PharmaTimes
December 14, 2021
A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.
-
50 Years of Progress in Treating Patients with Cancer
FDA
December 13, 2021
By Richard Pazdur, MD, Director, Oncology Center of Excellence (OCE) and Acting Director, Office of Oncologic Diseases (OOD)
-
LianBio Provides Corporate Update and Reports Third Quarter 2021 Financial Results
PhamaSources.com
December 10, 2021
LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.
-
Updated NCCN Distress Thermometer and Problem List Helps People Cope with Cancer Symptoms and Treatment
prnasia
December 07, 2021
The National Comprehensive Cancer Network (NCCN®)—a nonprofit alliance of leading cancer centers—announces updates to its widely-used resource for enabling discussion and treatment of distress as part of routine care...
-
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community
WorldPharmaNews
December 02, 2021
GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme will provide education on progress in ...
-
Late cancer diagnoses rise as NHS struggles with COVID-19
PharmaTimes
December 01, 2021
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic...
-
COVID-19 Booster Shot Helps Vast Majority of Cancer Patients
prnewswire
November 18, 2021
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center...
-
Trillium Therapeutics Receives Final Court Order Approving Arrangement
FirstWordPharma
October 29, 2021
Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce that...
-
NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
prnasia
October 25, 2021
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition.
-
World Liquid Biopsy Markets Report 2021: Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms - Forecast to 2025
prnewswire
October 13, 2021
The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2021-2025" report...